Company & Sponsor Intelligence
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.
Request enterprise analysis →Indexed trials2
Recruiting0
Completed2
Countries1
Therapeutic footprint
autism
Indexed studies
NCT05472870Efficacy and Mechanism of rTMS in Children With ASD: an Open-label Clinical Trial(Ⅱ)
autism · ChinaNA
autism · ChinaNA
NCT03156153A Study of Bumetanide for the Treatment of Autism Spectrum Disorders
autism · ChinaPHASE2
autism · ChinaPHASE2
Intelligence layer updated: 2026-06-10 02:57:56.223123+00:00
Enterprise intelligence
Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.
Request comparative intelligence →